Google to Invest $15 Billion in New Data Center and Promises Thousands of Jobs

 

A 60-year-old Danish woman who died of a blood clot after receiving the CCP virus vaccine from AstraZeneca had "very unusual" symptoms, the Danish Medicines Agency reported after evaluating the case.

 

As determined by the forensic study after her death, the woman died due to a low number of blood platelets and clots in small and large vessels, the result of internal bleeding after having applied the CCP virus vaccine from the AstraZeneca laboratory.

 

The Danish Medicines Agency reported that in Norway and in the database of drug side effects of the European Medicines Agency (EMA), several cases of death with very similar symptoms were found after applying the same vaccine.

 

Norwegian health authorities said on Saturday that three people, all under the age of 50, who had received the AstraZeneca vaccine were being treated in hospital for bleeding, blood clots and a low blood platelet count, which health authorities labeled as “ unusual symptoms ”.

 

AstraZeneca Plc defended itself saying that a review of its research data on people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of producing blood clots. However, the data that European countries are throwing do not suggest the same and last week ten countries of the European Union had already suspended the application of the British laboratory vaccine.

 

Now joined by Germany, France, Italy and Spain, who became the latest countries on Monday to suspend use of AstraZeneca's COVID-19 vaccine over reports of dangerous blood clots in some recipients, AP News reported.